Tenaya Therapeutics | IPO Presentation Deck | 36 slides · page 27 of 36
The slide outlines a proprietary R&D pipeline for identifying and validating drug targets using patient-derived cells and machine learning.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 list 1/1 title 2/2
Components 4
process bullet action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1